Breaking News Headlines Today

News about Gilead Sciences

Stay current with all the latest and breaking news about Gilead Sciences, compare headlines and perspectives between news sources on stories happening today. In total, 51 stories have been published about Gilead Sciences which Ground News has aggregated in the past 3 months.

Covered Most By

Local News Publishers

Suggest a source

Looking for a source we don't already have? Suggest one here.

James Uthmeier Says Pharma Company Ordered to Pay Florida $3M in HIV Drug Kickback Lawsuit

100% Center coverage: 1 sources

Attorney General James Uthmeier announced Wednesday that a multimillion-dollar settlement has been reached with a pharmaceutical company accused of paying kickbacks to health providers involved with a drug used to treat HIV and AIDS patients. The company, Gilead Sciences Inc., was sued by Florida and several other states for allegedly requiring health care providers to promote its drugs in exchange for compensation. The HIV drugs included Stribi…See the Story

Uganda: Cheaper HIV Prevention Drug Coming

100% Center coverage: 2 sources

Novartis and Linde vs. Glaxosmithkline and Medigene – Commented Kw 39 Peer Group Watch Pharma, Chemistry, Biotech, Medicine & Health

James Uthmeier Says Pharma Company Ordered to Pay Florida $3M in HIV Drug Kickback Lawsuit

100% Center coverage: 1 sources

Zimbabwe: Twice-Yearly HIV Prevention Jab to Be Rolled Out in Zim

100% Center coverage: 1 sources

Zimbabwe has been chosen as one of just ten countries worldwide to introduce lenacapavir, a new HIV prevention drug hailed as a global game-changer.HIV · Harare See the Story

HIV prevention injection approved in EU amid calls for increased accessibility

100% Left coverage: 1 sources

This article is about an HIV prevention injection approved in the EU. In the photo, the hands of a doctor holding a syringe and medicine while wearing latex gloves. Via Unsplash - Nappy In August 2025, the European Commission formally approved the twice-yearly injection for HIV prevention developed by Gilead Sciences, making it available for countries in the EU. Since the jab was authorised in the US earlier in June, experts and activists have c…Gilead Sciences See the Story

What Gilead Sciences (GILD)'s Global HIV Partnership and US Manufacturing Expansion Means for Shareholders

In early September 2025, Gilead Sciences announced a partnership with the U.S. State Department and PEPFAR to expand access to its twice-yearly injectable HIV-1 prevention therapy, and began construction on a new Pharmaceutical Development and Manufacturing Technical Development Center at its Foster City headquarters. This move brings together global health partners to deliver lenacapavir to up to two million people and strengthens Gilead's dome…Gilead Sciences · Foster City Read Article

Lenacapavir to be rolled out via Pepfar to selected countries - Juta MedicalBrief

The news that the US Government has made a pre-market commitment to purchase the twice-yearly highly effective injectible drug lenacapavir from Gilead Sciences for the President’s Emergency Plan for Aids Relief (Pepfar) to distribute in eight to 12 high-burden HIV countries in 2026 has been welcomed by experts, including South Africans. Authorities say Pepfar “is seeking to meaningfully reduce the number of new HIV infections, especially in preg…Gilead Sciences · Cape Town Read Article

Life Sciences Giant Gilead Sciences Adopts Veeva's Next-Gen AI-Powered CRM Platform for Commercial Operations

Gilead Sciences selects Veeva Vault CRM Suite for commercial operations, featuring AI agents for pre-call planning, compliant text, and voice control. Partnership expands existing relationship.Artificial Intelligence See the Story

Best Pharmaceutical Stocks To Consider - September 6th

100% Center coverage: 1 sources

Eli Lilly and Company, Merck & Co., Inc., AbbVie, Honeywell International, Pfizer, Novo Nordisk A/S, and Gilead Sciences are the seven Pharmaceutical stocks to watch today, according to MarketBeat's stock screener tool. Pharmaceutical stocks are shares of publicly traded companies that research, deStock Markets Read Article

Leerink Partners Maintains Buy on Gilead Sciences (GILD)

Gilead Sciences, Inc. (NASDAQ:GILD) is one of the Most Undervalued S&P 500 Stocks to Buy Right Now. On September 2, Daina Graybosch from Leerink Partners maintained a Buy rating on Gilead Sciences, Inc. (NASDAQ:GILD) with a price target of $114. The analyst highlighted the strong position of the…Gilead Sciences Read Article

News about Gilead Sciences

News about Gilead Sciences

Covered Most By

Local News Publishers

Top Gilead Sciences News

Uganda: Cheaper HIV Prevention Drug Coming

Zimbabwe: Twice-Yearly HIV Prevention Jab to Be Rolled Out in Zim

James Uthmeier Says Pharma Company Ordered to Pay Florida $3M in HIV Drug Kickback Lawsuit

Uganda: Cheaper HIV Prevention Drug Coming

Novartis and Linde vs. Glaxosmithkline and Medigene – Commented Kw 39 Peer Group Watch Pharma, Chemistry, Biotech, Medicine & Health

James Uthmeier Says Pharma Company Ordered to Pay Florida $3M in HIV Drug Kickback Lawsuit

Zimbabwe: Twice-Yearly HIV Prevention Jab to Be Rolled Out in Zim

HIV prevention injection approved in EU amid calls for increased accessibility

What Gilead Sciences (GILD)'s Global HIV Partnership and US Manufacturing Expansion Means for Shareholders

Lenacapavir to be rolled out via Pepfar to selected countries - Juta MedicalBrief

Life Sciences Giant Gilead Sciences Adopts Veeva's Next-Gen AI-Powered CRM Platform for Commercial Operations

Best Pharmaceutical Stocks To Consider - September 6th

Leerink Partners Maintains Buy on Gilead Sciences (GILD)

Covered Most By

Media Bias Breakdown

Breaking News Topics Related to Gilead Sciences

Uganda: Cheaper HIV Prevention Drug Coming

Novartis and Linde vs. Glaxosmithkline and Medigene – Commented Kw 39 Peer Group Watch Pharma, Chemistry, Biotech, Medicine & Health

James Uthmeier Says Pharma Company Ordered to Pay Florida $3M in HIV Drug Kickback Lawsuit

Zimbabwe: Twice-Yearly HIV Prevention Jab to Be Rolled Out in Zim

HIV prevention injection approved in EU amid calls for increased accessibility

What Gilead Sciences (GILD)'s Global HIV Partnership and US Manufacturing Expansion Means for Shareholders

Lenacapavir to be rolled out via Pepfar to selected countries - Juta MedicalBrief

Life Sciences Giant Gilead Sciences Adopts Veeva's Next-Gen AI-Powered CRM Platform for Commercial Operations

Best Pharmaceutical Stocks To Consider - September 6th

Leerink Partners Maintains Buy on Gilead Sciences (GILD)